Catalyst Wire Dossier Catalyst Wire Dossier

SB424323

SB424323 · GlaxoSmithKline
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SB424323, covering 2017-01-16 to 2017-01-16. Get the full timeline:

Most recent: Clinical Trial Update: Use Of SB424323 With Aspirin In Non-Valvular Atrial Fibrillation In Patients At A Low Or Intermediate Risk For Stroke [Phase 2]

See pricing